| GO ID | Ontology | GO Term | Term Definition |
Proteins |
GO:0019265 | BP | glycine biosynthetic process, by transamination of glyoxylate | The chemical reactions and pathways resulting in the formation of glycine by the transamination of glyoxylate. |
AGXT |
GO:0019276 | BP | UDP-N-acetylgalactosamine metabolic process | The chemical reactions and pathways involving UDP-N-acetylgalactosamine, a substance composed of N-acetylgalactosamine, a common structural unit of oligosaccharides, in glycosidic linkage with uridine diphosphate. |
CSGALNACT1 |
GO:0019285 | BP | glycine betaine biosynthetic process from choline | The chemical reactions and pathways resulting in the formation of betaine (N-trimethylglycine) from the oxidation of choline. |
ALDH7A1 |
GO:0019287 | BP | isopentenyl diphosphate biosynthetic process, mevalonate pathway | The chemical reactions and pathways resulting in the formation of isopentenyl diphosphate, via the intermediate mevalonate. This pathway converts acetate, in the form of acetyl-CoA, to isopentenyl diphosphate (IPP), the fundamental unit in isoprenoid biosynthesis, through a series of mevalonate intermediates. |
MVD, MVK |
GO:0019290 | BP | siderophore biosynthetic process | The chemical reactions and pathways resulting in the formation of siderophores, low molecular weight Fe(III)-chelating substances made by aerobic or facultatively anaerobic bacteria, especially when growing under iron deficient conditions. The complexes of Fe(3+)-siderophores have very high stability constants and are taken up by specific transport systems by microorganisms; the subsequent release of iron requires enzymatic action. |
BDH2 |
GO:0019303 | BP | D-ribose catabolic process | The chemical reactions and pathways resulting in the breakdown of D-ribose (ribo-pentose). |
NUDT5 |
GO:0019310 | BP | inositol catabolic process | The chemical reactions and pathways resulting in the breakdown of inositol, 1,2,3,4,5,6-cyclohexanehexol, a growth factor for animals and microorganisms. |
MIOX |
GO:0019318 | BP | hexose metabolic process | The chemical reactions and pathways involving a hexose, any monosaccharide with a chain of six carbon atoms in the molecule. |
HKDC1 |
GO:0019319 | BP | hexose biosynthetic process | The chemical reactions and pathways resulting in the formation of hexose, any monosaccharide with a chain of six carbon atoms in the molecule. |
CHST15 |
GO:0019322 | BP | pentose biosynthetic process | The chemical reactions and pathways resulting in the formation of a pentose, any monosaccharide with a chain of five carbon atoms in the molecule. |
G6PD, PGD |
GO:0019341 | BP | dibenzo-p-dioxin catabolic process | The chemical reactions and pathways resulting in the breakdown of dibenzo-p-dioxin, a substance composed of two benzene rings linked by two ether bonds. |
CYP1A1 |
GO:0019343 | BP | cysteine biosynthetic process via cystathionine | The chemical reactions and pathways resulting in the formation of cysteine, via the intermediate cystathionine. |
CTH, CBS |
GO:0019344 | BP | cysteine biosynthetic process | The chemical reactions and pathways resulting in the formation of cysteine, 2-amino-3-mercaptopropanoic acid. |
CTH, CBS |
GO:0019346 | BP | transsulfuration | The interconversion of homocysteine and cysteine via cystathionine. In contrast with enteric bacteria and mammals, Saccharomyces cerevisiae has two transsulfuration pathways employing two separate sets of enzymes. |
MTHFD1, MPST, CTH, CBS |
GO:0019367 | BP | fatty acid elongation, saturated fatty acid | Elongation of a saturated fatty acid chain. |
ELOVL7, ELOVL1, ELOVL4, ELOVL6, ELOVL5 |
GO:0019369 | BP | arachidonic acid metabolic process | The chemical reactions and pathways involving arachidonic acid, a straight chain fatty acid with 20 carbon atoms and four double bonds per molecule. Arachidonic acid is the all-Z-(5,8,11,14)-isomer. |
CYP2D6, ALOX15, MAPK3, PLA2G4A, CYP1B1, DAGLB, MGLL, PNPLA8, PLA2G4C |
GO:0019370 | BP | leukotriene biosynthetic process | The chemical reactions and pathways resulting in the formation of leukotriene, a pharmacologically active substance derived from a polyunsaturated fatty acid, such as arachidonic acid. |
ALOX5, PLA2G5, SYK, MGST2, GGT7 |
GO:0019371 | BP | cyclooxygenase pathway | The chemical reactions and pathways by which prostaglandins are formed from arachidonic acid, and in which prostaglandin-endoperoxide synthase (cyclooxygenase) catalyzes the committed step in the conversion of arachidonic acid to the prostaglandin-endoperoxides PGG2 and PGH2. |
PTGES, CBR1, PTGS1, PTGS2, PTGDS, AKR1C3, PTGES3, PTGIS |
GO:0019372 | BP | lipoxygenase pathway | The chemical reactions and pathways by which an unsaturated fatty acid (such as arachidonic acid or linolenic acid) is converted to other compounds, and in which the first step is hydroperoxide formation catalyzed by lipoxygenase. |
GPX1, ALOX5, HPGD, ALOX15, PTGS2, GPX4 |
GO:0019373 | BP | epoxygenase P450 pathway | The chemical reactions and pathways by which arachidonic acid is converted to other compounds including epoxyeicosatrienoic acids and dihydroxyeicosatrienoic acids. |
CYP1A1, CYP2E1, CYP2A6, CYP2C9, CYP2B6, CYP1B1 |
GO:0019388 | BP | galactose catabolic process | The chemical reactions and pathways resulting in the breakdown of galactose, the aldohexose galacto-hexose. |
GALT, PGM1, GALE, PGM2 |
GO:0019391 | BP | glucuronoside catabolic process | The chemical reactions and pathways resulting in the breakdown of glucuronosides, compound composed of a hydroxy compound linked to a glucuronate residue. |
ABHD10 |
GO:0019395 | BP | fatty acid oxidation | The removal of one or more electrons from a fatty acid, with or without the concomitant removal of a proton or protons, by reaction with an electron-accepting substance, by addition of oxygen or by removal of hydrogen. |
PPARG, ACOX1, ADIPOQ, MAPK14, ADIPOR2, CYGB, ADIPOR1, HAO2, PPARGC1A |
GO:0019413 | BP | acetate biosynthetic process | The chemical reactions and pathways resulting in the formation of acetate, the anion of acetic acid. |
ACSS2, ACSS1 |
GO:0019417 | BP | sulfur oxidation | The chemical reactions and pathways resulting the addition of oxygen to elemental sulfur. |
MICAL2, MICAL1 |
GO:0019427 | BP | acetyl-CoA biosynthetic process from acetate | The chemical reactions and pathways resulting in the formation of acetyl-CoA from acetate, either directly or via acetylphosphate. |
ACSS2, ACSS1 |
GO:0019430 | BP | removal of superoxide radicals | Any process, acting at the cellular level, involved in removing superoxide radicals (O2-) from a cell or organism, e.g. by conversion to dioxygen (O2) and hydrogen peroxide (H2O2). |
CCS, SOD2, MPO, SOD3, NQO1, MT3, NOS3, PRDX2, PRDX1 |
GO:0019432 | BP | triglyceride biosynthetic process | The chemical reactions and pathways resulting in the formation of a triglyceride, any triester of glycerol. |
LPL, GK, LPIN1, GPAT3, LCLAT1, GPAT4, DGAT2, GPAM, AGPAT4, AGPAT3, PNPLA3 |
GO:0019433 | BP | triglyceride catabolic process | The chemical reactions and pathways resulting in the breakdown of a triglyceride, any triester of glycerol. |
FABP12, APOA1, APOE, APOC3, APOB, FABP3, LPL, FABP4, FABP6, FABP5, LIPE, APOA5, PNPLA5, PNPLA2, MGLL, PNPLA3 |
GO:0019439 | BP | aromatic compound catabolic process | The chemical reactions and pathways resulting in the breakdown of aromatic compounds, any substance containing an aromatic carbon ring. |
EPHX1, PON1 |
GO:0019441 | BP | tryptophan catabolic process to kynurenine | The chemical reactions and pathways resulting in the breakdown of tryptophan into other compounds, including kynurenine. |
KMO, KYNU |
GO:0019442 | BP | tryptophan catabolic process to acetyl-CoA | The chemical reactions and pathways resulting in the breakdown of tryptophan into other compounds, including acetyl-CoA. |
KYNU |
GO:0019448 | BP | L-cysteine catabolic process | The chemical reactions and pathways resulting in the breakdown of L-cysteine, the L-enantiomer of 2-amino-3-mercaptopropanoic acid, i.e. (2R)-2-amino-3-mercaptopropanoic acid. |
AGXT, CBS, CDO1 |
GO:0019451 | BP | L-cysteine catabolic process to pyruvate, using cysteine dioxygenase | The chemical reactions and pathways resulting in the breakdown into pyruvate of L-cystine, catalyzed by the enzyme cysteine dioxygenase (EC:1.13.11.20). |
CDO1 |
GO:0019464 | BP | glycine decarboxylation via glycine cleavage system | The chemical reactions and pathways resulting in the breakdown of glycine by oxidative cleavage to carbon dioxide, ammonia, and a methylene group, mediated by enzymes of the glycine cleavage complex. |
GCSH |
GO:0019470 | BP | 4-hydroxyproline catabolic process | The chemical reactions and pathways resulting in the breakdown of 4-hydroxyproline, C5H9NO3, a derivative of the amino acid proline. |
PRODH, GOT2 |
GO:0019471 | BP | 4-hydroxyproline metabolic process | The chemical reactions and pathways involving 4-hydroxyproline, C5H9NO3, a derivative of the amino acid proline. The presence of hydroxyproline is essential to produce stable triple helical tropocollagen, hence the problems caused by ascorbate deficiency in scurvy. This unusual amino acid is also present in considerable amounts in the major glycoprotein of primary plant cell walls. |
PRDX4, ERO1B, ERO1A |
GO:0019478 | BP | D-amino acid catabolic process | The chemical reactions and pathways resulting in the breakdown of D-amino acids, the D-enantiomers of amino acids. |
DTD2 |
GO:0019482 | BP | beta-alanine metabolic process | The chemical reactions and pathways involving beta-alanine (3-aminopropanoic acid), an achiral amino acid and an isomer of alanine. It occurs free (e.g. in brain) and in combination (e.g. in pantothenate) but it is not a constituent of proteins. |
AASDH |
GO:0019483 | BP | beta-alanine biosynthetic process | The chemical reactions and pathways resulting in the formation of beta-alanine (3-aminopropanoic acid), an achiral amino acid and an isomer of alanine. It occurs free (e.g. in brain) and in combination (e.g. in pantothenate) but it is not a constituent of proteins. |
DPYD |
GO:0019509 | BP | L-methionine biosynthetic process from methylthioadenosine | The generation of L-methionine (2-amino-4-(methylthio)butanoic acid) from methylthioadenosine. |
MTAP, ADI1 |
GO:0019510 | BP | S-adenosylhomocysteine catabolic process | The chemical reactions and pathways resulting in the breakdown of S-adenosylhomocysteine, forming homocysteine and then methionine. |
AHCY |
GO:0019511 | BP | peptidyl-proline hydroxylation | The hydroxylation of peptidyl-proline to form peptidyl-hydroxyproline. |
P4HA2, P3H2 |
GO:0019521 | BP | D-gluconate metabolic process | The chemical reactions and pathways involving D-gluconate, the anion of D-gluconic acid, the aldonic acid derived from glucose. |
PGD |
GO:0019530 | BP | taurine metabolic process | The chemical reactions and pathways involving taurine (2-aminoethanesulfonic acid), a sulphur-containing amino acid derivative important in the metabolism of fats. |
PHGDH, GHR, STAT5A, STAT5B |
GO:0019531 | MF | oxalate transmembrane transporter activity | Enables the transfer of oxalate from one side of the membrane to the other. Oxalate, or ethanedioic acid, occurs in many plants and is highly toxic to animals. |
SLC26A2, SLC26A11, SLC26A1 |
GO:0019532 | BP | oxalate transport | The directed movement of oxalate into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. Oxalate, or ethanedioic acid, occurs in many plants and is highly toxic to animals. |
SLC26A2, SLC26A11, SLC26A1 |
GO:0019534 | MF | toxin transporter activity | Enables the directed movement of a toxin into, out of or within a cell, or between cells. A toxin is a poisonous compound (typically a protein) that is produced by cells or organisms and that can cause disease when introduced into the body or tissues of an organism. |
LRP6, SLC22A3, SLC7A8 |
GO:0019538 | BP | protein metabolic process | The chemical reactions and pathways involving a specific protein, rather than of proteins in general. Includes protein modification. |
BAG2, MMP16, NECAB3 |
GO:0019542 | BP | propionate biosynthetic process | The chemical reactions and pathways resulting in the formation of propionate, the anion derived from propionic acid. |
ACSS2, ACSS1 |
GO:0019550 | BP | glutamate catabolic process to aspartate | The chemical reactions and pathways resulting in the breakdown of glutamate into other compounds, including aspartate. |
GOT2 |
GO:0019551 | BP | glutamate catabolic process to 2-oxoglutarate | The chemical reactions and pathways resulting in the breakdown of glutamate into other compounds, including 2-oxoglutarate. |
GOT2 |
GO:0019563 | BP | glycerol catabolic process | The chemical reactions and pathways resulting in the breakdown of glycerol, 1,2,3-propanetriol, a sweet, hygroscopic, viscous liquid, widely distributed in nature as a constituent of many lipids. |
GK, GPD2, TPI1, GK5 |
GO:0019626 | BP | short-chain fatty acid catabolic process | The chemical reactions and pathways resulting in the breakdown of fatty acids with a chain length of less than C6. |
PCCA, MMAA, MCEE |
GO:0019627 | BP | urea metabolic process | The chemical reactions and pathways involving urea, the water soluble compound O=C-(NH2)2. |
CYP2C9 |
GO:0019640 | BP | glucuronate catabolic process to xylulose 5-phosphate | The chemical reactions and pathways resulting in the breakdown of glucuronate into other compounds, including xylulose 5-phosphate. |
SORD, DCXR, CRYL1 |
GO:0019673 | BP | GDP-mannose metabolic process | The chemical reactions and pathways involving GDP-mannose, a substance composed of mannose in glycosidic linkage with guanosine diphosphate. |
GMDS, GUK1 |
GO:0019674 | BP | NAD metabolic process | The chemical reactions and pathways involving nicotinamide adenine dinucleotide (NAD), a coenzyme present in most living cells and derived from the B vitamin nicotinic acid. |
KMO, LDHA, LDHB, QPRT, NADK2, NADSYN1, NMNAT3 |
GO:0019695 | BP | choline metabolic process | The chemical reactions and pathways involving choline (2-hydroxyethyltrimethylammonium), an amino alcohol that occurs widely in living organisms as a constituent of certain types of phospholipids and in the neurotransmitter acetylcholine. |
CHKA, DMGDH |
GO:0019706 | MF | protein-cysteine S-palmitoyltransferase activity | Catalysis of the transfer of a palmitoyl group to a sulfur atom on the cysteine of a protein molecule. |
ZDHHC20, ZDHHC17, ZDHHC14, ZDHHC6, ZDHHC7, ZDHHC2, ZDHHC9 |
GO:0019722 | BP | calcium-mediated signaling | Any intracellular signal transduction in which the signal is passed on within the cell via calcium ions. |
TNFSF11, EDN1, CXCL8, CCL3, SELE, PLCG2, EDN2, AGTR1, HTR2B, CXCR4, NCALD, MCTP1, TPCN2, RYR2, SPHK1 |
GO:0019724 | BP | B cell mediated immunity | Any process involved with the carrying out of an immune response by a B cell, through, for instance, the production of antibodies or cytokines, or antigen presentation to T cells. |
FAS, MSH2 |
GO:0019725 | BP | cellular homeostasis | Any process involved in the maintenance of an internal steady state at the level of the cell. |
CCL2, MCL1, TNS2 |
GO:0019730 | BP | antimicrobial humoral response | An immune response against microbes mediated through a body fluid. Examples of this process are seen in the antimicrobial humoral response of Drosophila melanogaster and Mus musculus. |
DEFA4, BCL3 |
GO:0019731 | BP | antibacterial humoral response | An immune response against bacteria mediated through a body fluid. Examples of this process are the antibacterial humoral responses in Mus musculus and Drosophila melanogaster. |
HIST1H2BK, ANG, SLPI, APP, DEFA4, HLA-E, ADM, B2M, HIST1H2BC, HIST2H2BE |
GO:0019732 | BP | antifungal humoral response | An immune response against a fungus mediated through a body fluid. An example of this process is the antifungal humoral response in Drosophila melanogaster. |
ANG, APP |
GO:0019740 | BP | nitrogen utilization | A series of processes that forms an integrated mechanism by which a cell or an organism detects the depletion of primary nitrogen source, usually ammonia, and then activates genes to scavenge the last traces of the primary nitrogen source and to transport and metabolize alternative nitrogen sources. The utilization process begins when the cell or organism detects nitrogen levels, includes the activation of genes whose products detect, transport or metabolize nitrogen-containing substances, and ends when nitrogen is incorporated into the cell or organism's metabolism. |
RHBG |
GO:0019747 | BP | regulation of isoprenoid metabolic process | Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving isoprenoids. |
NPC2 |
GO:0019752 | BP | carboxylic acid metabolic process | The chemical reactions and pathways involving carboxylic acids, any organic acid containing one or more carboxyl (COOH) groups or anions (COO-). |
MIF, CSAD |
GO:0019763 | MF | immunoglobulin receptor activity | Combining with the Fc region of an immunoglobulin protein and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity. |
FCGR1B |
GO:0019773 | CC | proteasome core complex, alpha-subunit complex | The proteasome core subcomplex that constitutes the two outer rings of the proteasome core complex. An example of this component is found in Mus musculus. |
PSMA1, PSMA2, PSMA3, PSMA4 |
GO:0019774 | CC | proteasome core complex, beta-subunit complex | The proteasome core subcomplex that constitutes the two inner rings of the proteasome core complex. An example of this component is found in Mus musculus. |
PSMB3 |
GO:0019776 | MF | Atg8 ligase activity | Catalysis of the covalent attachment of the ubiquitin-like protein Atg8 to substrate molecules; phosphatidylethanolamine is a known substrate. |
ATG12 |
GO:0019777 | MF | Atg12 transferase activity | Catalysis of the transfer of ATG12 from one protein to another via the reaction X-ATG12 + Y --> Y-ATG12 + X, where both X-ATG12 and Y-ATG12 are covalent linkages. |
ATG10 |
GO:0019780 | MF | FAT10 activating enzyme activity | Catalysis of the activation of the small ubiquitin-related modifier FAT10, through the formation of an ATP-dependent high-energy thiolester bond. |
UBA6 |
GO:0019781 | MF | NEDD8 activating enzyme activity | Catalysis of the initiation of the NEDD8 (RUB1) conjugation cascade. |
NAE1 |
GO:0019782 | MF | ISG15 activating enzyme activity | Catalysis of the activation of the small ubiquitin-related modifier ISG15, through the formation of an ATP-dependent high-energy thiolester bond. |
UBA7 |
GO:0019784 | MF | NEDD8-specific protease activity | Catalysis of the hydrolysis of NEDD8, a small ubiquitin-related modifier, from previously neddylated substrates. |
OTUB2, OTUB1 |
GO:0019787 | MF | ubiquitin-like protein transferase activity | Catalysis of the transfer of a ubiquitin-like from one protein to another via the reaction X-ULP + Y --> Y-ULP + X, where both X-ULP and Y-ULP are covalent linkages. ULP represents a ubiquitin-like protein. |
ITCH, RNF14, ARIH1 |
GO:0019788 | MF | NEDD8 transferase activity | Catalysis of the transfer of NEDD8 from one protein to another via the reaction X-NEDD8 + Y --> Y-NEDD8 + X, where both X-NEDD8 and Y-NEDD8 are covalent linkages. |
UBE2M, RBX1 |
GO:0019789 | MF | SUMO transferase activity | Catalysis of the transfer of SUMO from one protein to another via the reaction X-SUMO + Y --> Y-SUMO + X, where both X-SUMO and Y-SUMO are covalent linkages. |
RANBP2, SUMO2, UBE2I, MDM2, HDAC7 |
GO:0019797 | MF | procollagen-proline 3-dioxygenase activity | Catalysis of the reaction: procollagen L-proline + 2-oxoglutarate + O2 = procollagen trans-3-hydroxy-L-proline + succinate + CO2. |
P3H2 |
GO:0019800 | BP | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan | The formation of a cross-link between peptide chains mediated by a chondroitin 4-sulfate glycosaminoglycan that originates from a typical O-glycosidic link to serine of one chain; the other chain is esterified, via the alpha-carbon of its C-terminal Asp, to C-6 of an internal N-acetylgalactosamine of the glycosaminoglycan chain. |
DCN, BGN, NDNF, SPOCK2, SPOCK3 |
GO:0019805 | BP | quinolinate biosynthetic process | The chemical reactions and pathways resulting in the formation of quinolinate, the anion of quinolinic acid, also known as 2,3-pyridinedicarboxylic acid. |
KMO, KYNU |
GO:0019809 | MF | spermidine binding | Interacting selectively and non-covalently with spermidine, N-(3-aminopropyl)-1,4-diaminobutane. |
SAT1, SAT2 |
GO:0019810 | MF | putrescine binding | Interacting selectively and non-covalently with putrescine, 1,4-diaminobutane, the polyamine formed by decarboxylation of ornithine and the metabolic precursor of spermidine and spermine. |
AMD1 |
GO:0019815 | CC | B cell receptor complex | An immunoglobulin complex that is present in the plasma membrane of B cells and that in its canonical form is composed of two identical immunoglobulin heavy chains and two identical immunoglobulin light chains and a signaling subunit, a heterodimer of the Ig-alpha and Ig-beta proteins. |
SYK |
GO:0019825 | MF | oxygen binding | Interacting selectively and non-covalently with oxygen (O2). |
CYP26A1, ALB, CYP1A1, CYP17A1, CYP2E1, TH, CYP3A4, CYP2D6, CYP19A1, CYP2C9, CYP2B6, CYP3A5, CYP3A7, CBS, HBB, HBG1, HBA1, CYP1B1, CYP2U1, CYGB, NGB, CYP8B1 |
GO:0019826 | MF | oxygen sensor activity | Interacting selectively and non-covalently with and responding, e.g. by conformational change, to changes in the cellular level of oxygen (O2). |
NOX4 |
GO:0019827 | BP | stem cell population maintenance | The process by which an organism or tissue maintains a population of stem cells of a single type. This can be achieved by a number of mechanisms: stem cell asymmetric division maintains stem cell numbers; stem cell symmetric division increases them; maintenance of a stem cell niche maintains the conditions for commitment to the stem cell fate for some types of stem cell; stem cells may arise de novo from other cell types. |
KLF4, MED7, MED14, FZD7, EIF4E, KIT, LIF, CTNNB1, BMPR1A, NOTCH2, MED21, SMC1A, RIF1, NIPBL, NKAP, SETD6, RTF1, MED12, MED30, TRIM8, LIN28A, METTL14, EIF4ENIF1, MED17, ZNF358, PADI4, SMC3, MTF2 |
GO:0019828 | MF | aspartic-type endopeptidase inhibitor activity | Stops, prevents or reduces the activity of aspartic-type endopeptidases, enzymes that catalyze the hydrolysis of nonterminal peptide bonds in a polypeptide chain; the optimum reaction pH is below 5 due to an aspartic residue involved in the catalytic process. |
WFDC2 |
GO:0019829 | MF | cation-transporting ATPase activity | Catalysis of the transfer of a solute or solutes from one side of a membrane to the other according to the reaction: ATP + H2O + cation(out) = ADP + phosphate + cation(in). |
ATP13A5, ATP13A3, ATP13A2 |
GO:0019834 | MF | phospholipase A2 inhibitor activity | Stops, prevents or reduces the activity of the enzyme phospholipase A2. |
ANXA1, ANXA2, ANXA3 |
GO:0019835 | BP | cytolysis | The rupture of cell membranes and the loss of cytoplasm. |
C8G, C7, C6, LYZ, MMD, MICB, MICA |
GO:0019836 | BP | hemolysis by symbiont of host erythrocytes | The cytolytic destruction of red blood cells, with the release of intracellular hemoglobin, in the host organism by a symbiont. The host is defined as the larger of the organisms involved in a symbiotic interaction. |
ALB |
GO:0019838 | MF | growth factor binding | Interacting selectively and non-covalently with any growth factor, proteins or polypeptides that stimulate a cell or organism to grow or proliferate. |
SDCBP, NRP1, NRP2, A2M, ERBB2, ERBB3, ACVR2A, DUSP1, FLT4, ACVR1B, TGFBR1, IL6ST, LIFR, TEK, ACVR2B, BMPR2, RHBDF1, OSMR |
GO:0019840 | MF | isoprenoid binding | Interacting selectively and non-covalently with any isoprenoid compound, isoprene (2-methylbuta-1,3-diene) or compounds containing or derived from linked isoprene (3-methyl-2-butenylene) residues. |
PGGT1B |
GO:0019841 | MF | retinol binding | Interacting selectively and non-covalently with retinol, vitamin A1, 2,6,6-trimethyl-1-(9'-hydroxy-3',7'-dimethylnona-1',3',5',7'-tetraenyl)cyclohex-1-ene, one of the three components that makes up vitamin A. Retinol is an intermediate in the vision cycle and it also plays a role in growth and differentiation. |
RBP4, C8G, RBP1, ADH7 |
GO:0019843 | MF | rRNA binding | Interacting selectively and non-covalently with ribosomal RNA. |
ANG, RPS4Y1, RPL12, RPS9, RPS5, RPL37, RPS18, RPS11, RPL23A, RPL11, RNASEL, EMG1, PTCD3, DDX28, MRPL16, NOL12, SBDS |
GO:0019852 | BP | L-ascorbic acid metabolic process | The chemical reactions and pathways involving L-ascorbic acid, (2R)-2-[(1S)-1,2-dihydroxyethyl]-4-hydroxy-5-oxo-2,5-dihydrofuran-3-olate; L-ascorbic acid is vitamin C and has co-factor and anti-oxidant activities in many species. |
CYB5A, CYB5R3, SLC2A1, SLC2A3, GCLC, GSTO1, GSTO2, SLC23A2 |